New Phase 3 Data for Tradjenta ® (linagliptin) Tablets
May 24, 2012 (Boehringer Ingelheim) — New Phase 3 data for Tradjenta ® (linagliptin) tablets in black or African American patients with type 2 diabetes showed significant improvement in blood sugar. First published trial of a dipeptidyl peptidase-4 (DPP-4) inhibitor specifically conducted in black or African American patients with type 2 diabetes.
read more (Source: Diabetes News from dLife.com)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div
Rabies: hospital launches probe into why woman was turned away
A hospital has launched an investigation into how a women suffering from rabies was twice turned away from its accident and emergency department without treatment. (Source: Telegraph Health)
